Massoure P L, Constans J, Caudry M, Morlat P, Skopinski S, Beylot J, Longy-Boursier M, Le Bras M, Combe C, Quinton A, Saric J, Conri C
Service de Médecine Interne et Pathologie Vasculaire, Hôpital Saint-André, 1 rue Jean Burguet, 33075 Bordeaux Cedex.
J Mal Vasc. 2000 Oct;25(4):250-5.
Deep venous thrombosis is 50 times less frequent in upper than in lower limbs. Data remain poor in the literature. Forty consecutive patients (24 males, 16 females, mean age: 54.5 years) were retrospectively analysed from 161 subjects who underwent venous explorations of the upper extremity for a 3.5 year period in the same center. Diagnosis of thrombosis was made by duplex ultrasonography (n =37) or phlebography (n =3). Main clinical manifestations were edema (n =36) and pain (n =29). Location of thrombosis was humeral (n =1), axillary (n =2), or sub-clavian (n =37, 2 bilateral). The majority of thrombosis (n =29) were secondary to cancer and venous catheter (n =19, 15 implanted ports), to central catheter alone (n =3) or cancer alone (n =7). The 11 others were associated with thoracic outlet syndrome (n =6) or apparent primary thrombosis (n =5). Thrombophilia was identified in 6 out of these 11. During follow up [mean of 9 months (0,5-36)], two patients developed pulmonary embolism, 14 a post-thrombotic syndrome and 16 patients died. Initial therapy included heparin (n =36) or fibrinolysis (n =4). Upper extremity deep venous thrombosis are mostly associated with cancers and venous catheters. Thrombophilia is frequent in the other cases. Heparin followed by oral anticoagulation is the optimal therapy whose duration depends upon underlying condition. Fibrinolysis has not been useful for preventing post-thrombotic syndrome in our study.
上肢深静脉血栓形成的发生率比下肢低50倍。文献中的数据仍然较少。对同一中心在3.5年期间接受上肢静脉探查的161名受试者中的40例连续患者(24例男性,16例女性,平均年龄:54.5岁)进行了回顾性分析。血栓形成的诊断通过双功超声检查(n = 37)或静脉造影(n = 3)做出。主要临床表现为水肿(n = 36)和疼痛(n = 29)。血栓形成的部位为肱骨(n = 1)、腋窝(n = 2)或锁骨下(n = 37,2例为双侧)。大多数血栓形成(n = 29)继发于癌症和静脉导管(n = 19,15例为植入式端口)、仅继发于中心静脉导管(n = 3)或仅继发于癌症(n = 7)。其他11例与胸廓出口综合征(n = 6)或明显的原发性血栓形成(n = 5)相关。在这11例中,6例发现有易栓症。在随访期间[平均9个月(0.5 - 36个月)] , 2例患者发生肺栓塞,14例发生血栓形成后综合征,16例患者死亡。初始治疗包括肝素(n = 36)或纤维蛋白溶解疗法(n = 4)。上肢深静脉血栓形成大多与癌症和静脉导管相关。在其他病例中易栓症很常见。肝素后口服抗凝是最佳治疗方法,其持续时间取决于基础疾病。在我们的研究中,纤维蛋白溶解疗法对预防血栓形成后综合征没有作用。